{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70748-173",
      "generic_name": "Sevelamer hydrochloride",
      "labeler_name": "Lupin Pharmaceuticals, Inc.",
      "brand_name": "Sevelamer hydrochloride",
      "active_ingredients": [
        {
          "name": "SEVELAMER HYDROCHLORIDE",
          "strength": "800 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70748-173-26",
          "description": "180 TABLET in 1 BOTTLE (70748-173-26)",
          "marketing_start_date": "20220225",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "857224"
        ],
        "spl_set_id": [
          "a56c857e-bc39-484c-908d-f5957857efbb"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "GLS2PGI8QG"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "cc130cfa-f3e5-460d-92a8-69cc0f958dd2",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20220225",
      "product_id": "70748-173_cc130cfa-f3e5-460d-92a8-69cc0f958dd2",
      "application_number": "ANDA213145",
      "brand_name_base": "Sevelamer hydrochloride",
      "pharm_class": [
        "Phosphate Binder [EPC]",
        "Phosphate Chelating Activity [MoA]"
      ]
    }
  ]
}